SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-370120
Filing Date
2013-09-18
Accepted
2013-09-18 12:16:59
Documents
3
Period of Report
2013-09-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d600342d8k.htm 8-K 20505
2 EX-99.1 d600342dex991.htm EX-99.1 8607
3 GRAPHIC g600342ex99_1.jpg GRAPHIC 7274
  Complete submission text file 0001193125-13-370120.txt   40429
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23186 | Film No.: 131103065
SIC: 2836 Biological Products, (No Diagnostic Substances)